Bo Liu

4.0k total citations
142 papers, 2.1k citations indexed

About

Bo Liu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Bo Liu has authored 142 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pulmonary and Respiratory Medicine, 44 papers in Molecular Biology and 39 papers in Oncology. Recurrent topics in Bo Liu's work include Ferroptosis and cancer prognosis (22 papers), Renal cell carcinoma treatment (14 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Bo Liu is often cited by papers focused on Ferroptosis and cancer prognosis (22 papers), Renal cell carcinoma treatment (14 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Bo Liu collaborates with scholars based in China, United States and France. Bo Liu's co-authors include Xianglin Yuan, Yuan Huang, Bangbei Wan, Cai Lv, Yang Tang, Zheng Huang, Gang Yu, Xia Lei, Jinjin Wu and Min Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Bo Liu

136 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Liu China 27 711 597 565 311 222 142 2.1k
Long Liu China 27 732 1.0× 568 1.0× 980 1.7× 673 2.2× 158 0.7× 136 2.4k
Sandra Freitag‐Wolf Germany 26 719 1.0× 402 0.7× 526 0.9× 199 0.6× 225 1.0× 103 2.9k
Sung Hwan Kim South Korea 25 540 0.8× 666 1.1× 267 0.5× 250 0.8× 246 1.1× 137 2.1k
Tatsuo Ito Japan 25 788 1.1× 561 0.9× 1.1k 2.0× 266 0.9× 144 0.6× 126 3.0k
Atsushi Kawaguchi Japan 30 543 0.8× 550 0.9× 357 0.6× 321 1.0× 235 1.1× 169 2.9k
Haiyang Wu China 23 311 0.4× 240 0.4× 462 0.8× 207 0.7× 144 0.6× 77 1.7k
Lei Zhao China 28 801 1.1× 475 0.8× 725 1.3× 397 1.3× 118 0.5× 231 2.7k
Liang Zhang China 24 633 0.9× 283 0.5× 514 0.9× 271 0.9× 324 1.5× 152 2.0k

Countries citing papers authored by Bo Liu

Since Specialization
Citations

This map shows the geographic impact of Bo Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Liu more than expected).

Fields of papers citing papers by Bo Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Liu. The network helps show where Bo Liu may publish in the future.

Co-authorship network of co-authors of Bo Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Liu. A scholar is included among the top collaborators of Bo Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Liu. Bo Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yuehua, Jingyao Tu, Sidan Tian, et al.. (2025). A Bifunctional Antibody Targeting PD-1 and TGF-β Signaling Has Antitumor Activity in Combination with Radiotherapy and Attenuates Radiation-Induced Lung Injury. Cancer Immunology Research. 13(5). 767–784. 1 indexed citations
2.
Yang, Chunguang, Basen Li, Yang Luan, et al.. (2024). Deep learning model for the detection of prostate cancer and classification of clinically significant disease using multiparametric MRI in comparison to PI-RADs score. Urologic Oncology Seminars and Original Investigations. 42(5). 158.e17–158.e27. 4 indexed citations
3.
4.
Dong, Hui, Hui Zhang, Lei Cai, et al.. (2024). Inflammatory Signaling Induces Mitochondrial Dysfunction and Neuronal Death in Traumatic Brain Injury via Downregulation of OXPHOS Genes. Biochemical Genetics. 63(6). 5394–5414. 4 indexed citations
5.
Ma, Li, Xinyi Chen, Yulong Yu, et al.. (2024). TNKS1BP1 facilitates ubiquitination of CNOT4 by TRIM21 to promote hepatocellular carcinoma progression and immune evasion. Cell Death and Disease. 15(7). 511–511. 8 indexed citations
6.
Li, Chunya, Jingyao Tu, Chaofan Liu, et al.. (2024). ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I. Cell Death and Disease. 15(7). 519–519. 13 indexed citations
7.
Liu, Bo, et al.. (2023). A study on the survival prediction for patients with oral cancer in southwest China. Oral Diseases. 30(3). 966–976. 5 indexed citations
8.
Ji, Yiyi, Xiang Zhou, Bo Liu, et al.. (2023). 18F‐FDG PET/CT imaging in neuroendocrine prostate cancer: Relation to histopathology and prognosis. The Prostate. 83(12). 1167–1175. 3 indexed citations
9.
Ji, Yiyi, Bo Liu, Lei Chen, et al.. (2023). Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathway. Cellular Oncology. 46(5). 1445–1456. 10 indexed citations
10.
Jin, Meng, Bo Liu, Yongbiao Huang, et al.. (2023). Genome-Wide Splicing Quantitative Expression Locus Analysis Identifies Causal Risk Variants for Non–Small Cell Lung Cancer. Cancer Research. 83(10). 1742–1756. 10 indexed citations
11.
Ma, Sheng, Yue Ge, Yanan Wang, et al.. (2023). A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma. PeerJ. 11. e14784–e14784. 5 indexed citations
12.
Liu, Bo, et al.. (2023). A bibliometric analysis of research on R-loop: Landscapes, highlights and trending topics. DNA repair. 127. 103502–103502. 5 indexed citations
13.
Li, Qinyu, et al.. (2023). The role of calcium channels in prostate cancer progression and potential as a druggable target for prostate cancer treatment. Critical Reviews in Oncology/Hematology. 186. 104014–104014. 5 indexed citations
14.
Huang, Yongbiao, Ye Yuan, Sheng Chen, et al.. (2022). Identifying potential pharmacological targets and mechanisms of vitamin D for hepatocellular carcinoma and COVID-19. Frontiers in Immunology. 13. 985781–985781. 3 indexed citations
15.
Dong, Tianhua, Fei Zhang, Bo Liu, et al.. (2018). Epidemiological comparison of adult talus fractures between East China and West China from 2010 to 2011. Zhonghua chuangshang guke zazhi. 20(8). 712–716. 2 indexed citations
16.
Schmid, Peter, Cristina Cruz, Fadi S. Braiteh, et al.. (2017). Abstract 2986: Atezolizumab in metastatic TNBC (mTNBC): Long-term clinical outcomes and biomarker analyses. Cancer Research. 77(13_Supplement). 2986–2986. 92 indexed citations
17.
18.
Liu, Bo, et al.. (2015). Clinical characteristics and prognosis of novel bunyavirus infection: 68-case report. 33(2). 75–78. 1 indexed citations
19.
Feng, Min, Jun Lv, Sha Fu, et al.. (2014). Clinical features and mortality in Chinese with lupus nephritis and neuropsychiatric lupus: A 124-patient study. SHILAP Revista de lepidopterología. 8 indexed citations
20.
Li, Qianxia, Ju Dong Yang, Qianqian Yu, et al.. (2013). Associations between Single-Nucleotide Polymorphisms in the PI3K–PTEN–AKT–mTOR Pathway and Increased Risk of Brain Metastasis in Patients with Non–Small Cell Lung Cancer. Clinical Cancer Research. 19(22). 6252–6260. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Long Liu Breakdown of academic impact, for papers by Sandra Freitag‐Wolf Breakdown of academic impact, for papers by Sung Hwan Kim Breakdown of academic impact, for papers by Tatsuo Ito Breakdown of academic impact, for papers by Atsushi Kawaguchi Breakdown of academic impact, for papers by Haiyang Wu Breakdown of academic impact, for papers by Lei Zhao Breakdown of academic impact, for papers by Liang Zhang
Rankless by CCL
2026